Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02994667 · ClinicalTrials.gov registry record

Pacemaker Utilization and Ventricular Pacing in Patients Undergoing Trans-catheter Aortic Valve Replacement (TAVR)

A clinical trial, sponsored by Baylor Research Institute.

Completed
Registry status
30
Enrollment target

NCT02994667 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02994667 has completed, sponsored by Baylor Research Institute.

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

The purpose of this study is to assess the incidence (at 90-days) of ventricular pacing in patients undergoing permanent pacemaker placement after TAVR. As well as incidence (at 90-days) of atrioventricular block (AVB), intraventricular conduction delay (IVCD), bundle branch block (BBB), and rate histogram in patients undergoing permanent pacemaker placement after TAVR.

Interventions

  • DEVICE Permanent Pacemaker Placement

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2015-01
Est. Completion 2019-12-20

Sponsor

Baylor Research Institute

180 total trials

What the Registry Record Tells You About NCT02994667

The ClinicalTrials.gov registry entry for NCT02994667 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Permanent Pacemaker Placement is the first listed.

NCT02994667 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02994667 about?

NCT02994667 is a clinical study titled "Pacemaker Utilization and Ventricular Pacing in Patients Undergoing Trans-catheter Aortic Valve Replacement (TAVR)". The purpose of this study is to assess the incidence (at 90-days) of ventricular pacing in patients undergoing permanent pacemaker placement after TAVR. As well as incidence (at 90-days) of atrioventricular block (AVB), intraventricular conduction delay (IVCD), bundle branch block (BBB), and rate h...

What is the current status of trial NCT02994667?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2015-01. Estimated completion is 2019-12-20.

What interventions are being tested in trial NCT02994667?

The interventions under investigation include: Permanent Pacemaker Placement (DEVICE).

Who is sponsoring clinical trial NCT02994667?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.